{"id":"https://openalex.org/W153453255","doi":null,"title":"Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use.","display_name":"Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use.","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W153453255","mag":"153453255","pmid":"https://pubmed.ncbi.nlm.nih.gov/22199446","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3233339"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3233339","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3233339","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tex Heart Inst J","raw_type":"Text"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3233339","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016150099","display_name":"Mervyn B. Forman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095179","display_name":"Saint Joseph's Hospital","ror":"https://ror.org/00m72p590","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4210095179"]},{"id":"https://openalex.org/I4210117921","display_name":"Saint Joseph\u2019s Translational Research Institute","ror":"https://ror.org/02esr1a07","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210117921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mervyn B Forman","raw_affiliation_strings":["Saint Joseph's Translational Research Institute, Saint Joseph's Hospital, Atlanta, Georgia 30342, USA. formanm@bellsouth.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Joseph's Translational Research Institute, Saint Joseph's Hospital, Atlanta, Georgia 30342, USA. formanm@bellsouth.net","institution_ids":["https://openalex.org/I4210095179","https://openalex.org/I4210117921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050799778","display_name":"Paul G. Sutej","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul G Sutej","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005780035","display_name":"Edwin Kerry Jackson","orcid":"https://orcid.org/0000-0002-8101-6009","observed_orcids":["https://orcid.org/0000-0002-8101-6009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edwin K Jackson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6584,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.74517747,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"38","issue":"6","first_page":"714","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12082","display_name":"Takotsubo Cardiomyopathy and Associated Phenomena","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12082","display_name":"Takotsubo Cardiomyopathy and Associated Phenomena","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10882","display_name":"Cardiomyopathy and Myosin Studies","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12230","display_name":"Cardiovascular Issues in Pregnancy","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/milnacipran","display_name":"milnacipran","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-induced-cardiomyopathy","display_name":"drug-induced cardiomyopathy","score":0.902999997138977},{"id":"https://openalex.org/keywords/catecholamine-induced-cardiomyopathy","display_name":"catecholamine-induced cardiomyopathy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.628000020980835},{"id":"https://openalex.org/keywords/tachycardia","display_name":"tachycardia","score":1.0},{"id":"https://openalex.org/keywords/hyperadrenergic-state","display_name":"hyperadrenergic state","score":0.8830000162124634},{"id":"https://openalex.org/keywords/plasma-catecholamines","display_name":"plasma catecholamines","score":0.7400000095367432},{"id":"https://openalex.org/keywords/fibromyalgia","display_name":"fibromyalgia","score":0.847000002861023},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7379999756813049},{"id":"https://openalex.org/keywords/connective-tissue-diseases","display_name":"connective tissue diseases","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C2780199185","wikidata":"https://www.wikidata.org/wiki/Q421058","display_name":"Milnacipran","level":4,"score":0.9503079652786255},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8864917755126953},{"id":"https://openalex.org/C2778797674","wikidata":"https://www.wikidata.org/wiki/Q847583","display_name":"Cardiomyopathy","level":3,"score":0.8510852456092834},{"id":"https://openalex.org/C2777831278","wikidata":"https://www.wikidata.org/wiki/Q540571","display_name":"Fibromyalgia","level":2,"score":0.659509003162384},{"id":"https://openalex.org/C2775894120","wikidata":"https://www.wikidata.org/wiki/Q271663","display_name":"Catecholamine","level":2,"score":0.6124051809310913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.572819173336029},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.555908739566803},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5159516930580139},{"id":"https://openalex.org/C2778178275","wikidata":"https://www.wikidata.org/wiki/Q1649897","display_name":"Catecholaminergic polymorphic ventricular tachycardia","level":5,"score":0.4561859667301178},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.43070849776268005},{"id":"https://openalex.org/C2780283014","wikidata":"https://www.wikidata.org/wiki/Q209583","display_name":"Tachycardia","level":2,"score":0.41317352652549744},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.3100675046443939},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0},{"id":"https://openalex.org/C190712762","wikidata":"https://www.wikidata.org/wiki/Q18031341","display_name":"Ryanodine receptor 2","level":4,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C113217602","wikidata":"https://www.wikidata.org/wiki/Q416781","display_name":"Ryanodine receptor","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000078764","descriptor_name":"Milnacipran","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002317","descriptor_name":"Cardiovascular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002395","descriptor_name":"Catecholamines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013610","descriptor_name":"Tachycardia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013610","descriptor_name":"Tachycardia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D013610","descriptor_name":"Tachycardia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D013610","descriptor_name":"Tachycardia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017023","descriptor_name":"Coronary Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:3233339","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3233339","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tex Heart Inst J","raw_type":"Text"},{"id":"pmid:22199446","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22199446","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Texas Heart Institute journal","raw_type":"Case Reports"},{"id":"mag:153453255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22199446","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3233339","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3233339","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tex Heart Inst J","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8600000143051147,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W131238900","https://openalex.org/W132701132","https://openalex.org/W1963888704","https://openalex.org/W1973637626","https://openalex.org/W1983014423","https://openalex.org/W2002368528","https://openalex.org/W2011257319","https://openalex.org/W2012408437","https://openalex.org/W2013432168","https://openalex.org/W2014182808","https://openalex.org/W2030458983","https://openalex.org/W2035441052","https://openalex.org/W2036627681","https://openalex.org/W2037968404","https://openalex.org/W2040437210","https://openalex.org/W2045332418","https://openalex.org/W2085191520","https://openalex.org/W2125788603","https://openalex.org/W2141082799","https://openalex.org/W2146321056"],"related_works":["https://openalex.org/W2068512307","https://openalex.org/W1963888704","https://openalex.org/W2029146940","https://openalex.org/W2041050942","https://openalex.org/W101744326","https://openalex.org/W2085602650","https://openalex.org/W2474121929","https://openalex.org/W4387268538","https://openalex.org/W2120725233","https://openalex.org/W2426351634"],"abstract_inverted_index":{"Elevated":[0],"catecholamine":[1,14,95],"levels":[2],"are":[3],"a":[4,26,48,58,69,85,128],"well-recognized":[5],"cause":[6,130],"of":[7,10,13,31,57,78,99,104,111,125,131],"various":[8],"types":[9],"cardiomyopathy.":[11,133],"Causes":[12],"elevation":[15],"include":[16],"tumors,":[17],"toxins,":[18],"drugs,":[19],"emotional":[20],"stress,":[21],"and":[22,28,33,44,65,71,92,101],"sepsis.":[23],"Milnacipran":[24],"is":[25,37,121],"dual":[27],"equipotent":[29],"inhibitor":[30],"norepinephrine":[32],"serotonin":[34],"uptake.":[35],"It":[36],"frequently":[38],"prescribed":[39],"as":[40,127],"therapy":[41,106],"for":[42],"fibromyalgia,":[43],"the":[45,55,102,112,122],"drug":[46],"has":[47],"good":[49],"safety":[50],"profile.":[51],"Herein,":[52],"we":[53],"report":[54,124],"case":[56],"42-year-old":[59],"woman":[60],"with":[61,84],"undefined":[62],"connective-tissue":[63],"disease":[64],"fibromyalgia":[66],"who":[67],"developed":[68],"severe":[70],"reversible":[72],"cardiomyopathy":[73,81,113],"while":[74],"taking":[75],"recommended":[76],"doses":[77],"milnacipran.":[79],"The":[80,97],"was":[82],"associated":[83],"hyperadrenergic":[86],"state":[87],"manifested":[88],"by":[89],"tachycardia,":[90],"hypertension,":[91],"elevated":[93],"plasma":[94],"levels.":[96],"discontinuation":[98],"milnacipran":[100,126],"initiation":[103],"anti-failure":[105],"resulted":[107],"in":[108,114],"complete":[109],"resolution":[110],"6":[115],"months.":[116],"To":[117],"our":[118],"knowledge,":[119],"this":[120],"first":[123],"possible":[129],"catecholamine-induced":[132]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}